Startups
Cormorant Capital facilitates the growth of real estate-operator and owner clients by co-investing in select transactions. Cormorant also advises clients on equity solutions for new transactions and existing portfolios.
Projects include both development and cash-flowing opportunities. Cormorant can also assist lenders/special servicers in maximizing the value of legacy assets by seeking new partners identified for their specific operational expertise.
Projects include both development and cash-flowing opportunities. Cormorant can also assist lenders/special servicers in maximizing the value of legacy assets by seeking new partners identified for their specific operational expertise.
Overview
Location
United States, New York
Employees
11-50
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 15, 2024 | Freenome Raises $254M to Accelerate Early Cancer Detection Platform | What You Should Know: – Freenome, a leader in blood-based early cancer detection, has raised $254M in a new funding round, fueled by its innovative multiomics platform and promising pipeline of tests. The funding was led by Roche with parti... |
| Feb 9, 2024 | Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics | 09/02/2024 Nota de prensa YSIOS CAPITAL INVIERTE EN LA SERIE E DE 120 MILLONES DE DÓLARES DE NEURONA THERAPEUTICS Ysios Capital, gestora española líder en inversiones en el sector biotecnológico, ha anunciado hoy su participación en la rond... |
| Oct 19, 2020 | VectivBio secures $110 million to finance Phase III clinical trials | VectivBio closed a $110 million crossover financing from new investors Surveyor Capital (a Citadel company), Cormorant Capital and Eventide Asset Management, with participation from existing investors Versant Ventures, OrbiMed, Novo Holding... |
| Oct 19, 2020 | VectivBio secures $110 million to finance Phase III clinical trials |
Reviews 0
FAQ about Cormorant Capital
What has the press written about Cormorant Capital?
Parsers VC has collected 5 articles mentioning Cormorant Capital, among them “Freenome Raises $254M to Accelerate Early Cancer Detection Platform” (Feb 15, 2024) and “Ysios Capital invierte en la Serie E de 120 millones de dólares de Neurona Therapeutics” (Feb 9, 2024).
Is Cormorant Capital still active?
Yes, Cormorant Capital is active; its latest activity on Parsers VC dates from Feb 20, 2024.